World-Class Drug Development Capabilities World-Class Drug Development Capabilities

World-Class Drug
Development Capabilities

Program
Indication
Preclinical
Phase 1a/1b
Phase 2
Phase 3
Preclinical
Phase 1a/1b
Phase 2
Phase 3
PLN-101095

αvβ8/αvβ1 inhibitor

Solid Tumors
Solid Tumors
Preclinical
Phase 1a/1b
Phase 2
Phase 3
Muscle
Adipose tissue
Undisclosed
Muscle
Adipose tissue
Undisclosed

Expanding Possibilities

We will continue to evaluate additional indications to maximize the potential of our pipeline.

Our Science
right arrow
A person working in a lab